For the Media
Dr. Colleen Delaney is a member of Fred Hutch's Clinical Research Division and a director of Fred Hutch's Cord Blood Program. Her laboratory and clinical research is focused on the development of revolutionary techniques for improving outcomes from transplantation and changing the standards of care to help prevent infection and speed recovery after transplant or chemotherapy.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.